Celltrion’s Remsima SC Ready For Early 2020 Launch

Formal EU Approval Received For ‘Biobetter’ Subcutaneous Infliximab

 
• By Dave Wallace
  
2020_Cranes
Everything is falling into place for Celltrion’s subcutaneous infliximab launch in early 2020 • Source: Shutterstock

More from Biosimilars

More from Products